companydata.dkShire Biotech Denmark ApS: Financial statements 2016
CVR: 33358008
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 9,116,935 and a net result of DKK 775,583 compared with DKK 668,629 the year before. That is a decrease of 6.1% compared with the year before. Equity amounted to DKK 2,347,452. The solvency ratio was 30%.
- Gross Profit
- 9,116,935 kr.
- Profit/Loss
- 775,583 kr.
- Equity
- 2,347,452 kr.
- Total Assets
- 7,837,745 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 9.1 mio. | 776 t. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 669 t. | 1.6 mio. | - |
| 2014 | - | 7.2 mio. | 343 t. | 903 t. | - |
| 2013 | - | 4.8 mio. | 232 t. | 561 t. | - |
| 2012 | 4.1 mio. | 4.1 mio. | 93 t. | 329 t. | - |
How creditworthy is Shire Biotech Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
Shire Biotech Denmark ApS has published its annual report for 2015. Gross profit came to DKK 9,706,091, and the net result was DKK 668,629.
As of April 26, 2016, Amanda Miller has joined the board of directors of Shire Biotech Denmark ApS.
As of April 26, 2016, Jasper Sökeland has left the board of directors of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010 and dissolved in 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity amounted to DKK 3,207,794.